Address
304 North Cardinal
St. Dorchester Center, MA 02124

Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM

Omnitrope

$500.00

Omnitrope

2x30iu (60iu total) with injection device and needle tips included.

Cold shipping with this item. Domestic USA shipping

Category:

Omnitrope

Sandoz, a division of Novartis Pharmaceuticals, produces Omnitrope, a human growth hormone (HGH) brand. HGH, naturally produced by the pituitary gland, is vital for growth, cell regeneration, and maintaining body composition. Omnitrope, a synthetic form (somatropin) of HGH, addresses medical conditions linked to growth hormone deficiency.

 

Here are some key points to discuss about Omnitrope by Sandoz:

 

Medical Applications: Omnitrope is primarily prescribed for children and adults with growth hormone deficiency. In children, it fosters growth, while in adults, it manages conditions like growth hormone deficiency from pituitary tumors, muscle wasting in HIV patients, and short bowel syndrome.

Manufacturing Process: Omnitrope is crafted through recombinant DNA technology, producing a genetically engineered version of human growth hormone using specialized bacteria or mammalian cell lines. Sandoz, with its biotechnology expertise, has been manufacturing Omnitrope for years.

Forms and Dosages: Omnitrope is available in lyophilized powder for reconstitution, prefilled pens, and cartridges. The choice depends on patient needs and the physician’s recommendation.

Administration: Typically administered through subcutaneous injections, Omnitrope’s reconstituted solution is injected under the skin. The healthcare provider determines injection frequency and dosage based on the individual’s condition and treatment goals.

Safety and Side Effects: Omnitrope, like any medication, may have side effects. Common ones include injection site reactions, headache, muscle or joint pain, swelling, and water retention. Serious side effects, though rare, may include allergic reactions and an increased tumor risk, especially in patients with a cancer history. It’s vital for patients to discuss potential risks and benefits with their healthcare provider before starting treatment.

Monitoring and Long-Term Management: Patients under Omnitrope therapy need regular monitoring of growth, hormone levels, and other relevant parameters. Healthcare providers assess treatment response and adjust dosages accordingly. Long-term management involves consistent adherence to the prescribed treatment plan and regular follow-up visits for optimal outcomes.